Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 43

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 43
---
 our common stock may not be permitted to exercise the Pre-Funded Warrants that they hold.

A
holder of the Pre-Funded Warrants will not be entitled to exercise any portion of any Pre-Funded Warrant that, upon giving effect to such
exercise, would cause: (i) the aggregate number of shares of our common stock beneficially owned by such holder (together with its affiliates)
to exceed 4.99% (or, upon election of holder, 9.99%) of the number of shares of our common stock outstanding immediately after giving
effect to the exercise; or (ii) the combined voting power of our securities beneficially owned by such holder (together with its affiliates)
to exceed 4.99% (or, upon election of holder, 9.99%) of the combined voting power of all of our securities outstanding immediately after
giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrants. As
a result, you may not be able to exercise your Pre-Funded Warrants for shares of our common stock at a time when it would be financially
beneficial for you to do so. In such a circumstance, you could seek to sell your Pre-Funded Warrants to realize value, but you may be
unable to do so in the absence of an established trading market and due to applicable transfer restrictions.

| 22 |

<div align='center'>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This prospectus and the documents
incorporated herein by reference contain forward-looking statements. The forward-looking statements are contained principally in the sections
entitled “Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” and “Business” in this prospectus or the documents incorporated herein by reference. These statements
relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors which
may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements about:

| · | our ability to successfully commercialize our products and technology, including our Hemopurifier;             |
| · | our ability to raise additional capital to meet our working capital needs;                                     |
| · | the timing and results of future clinical trials;                                                              |
| ·